Femara Product Description
Femara is sn antitumour agent, used for managing different forms of cancer that develops and spreads through the breast tissue. The drug is prescribed to women with abnormal levels of estrogen, caused by postmenopausal.
Femara is an antitumour agent of the first or second-line treatment of such medical conditions like breast cancer, including if the disease is advanced, in progression, metastatic or hormone-dependent.
To obtain the estrogen-lowering effect in the peripheral and tumor tissues, use one Femara 2.5 mg pills with an interval of 24 hours. The dosage adjusting is not required for women over 50 years.
If you did not take a Femara pill in due time, you should take the missed dose as soon as you remember. However, you should not take Femara, if the time is approaching for your next dose. Just follow the usual dosing schedule starting from the next day.
Femara can be used, when other methods of hormonal treatment were ineffective. Safety and efficacy of long-term use of Femara (60 months) have been proved in clinical trials.
Keep the antineoplastic agent Femara in the original package at room temperature (not above 30°C). Keep out of reach and sight of children and pets.
Femara Safety Information
The antineoplastic agent Femara is intended for women, who have a clear exact menopausal status. If Femara pills are prescribed for a long-term use, you should regularly pass tests on bone mineral density and other measures to reduce the risks of osteoporosis.
Information on Femara, given in this report, is intended solely for informational purposes. All information about Femara is not meant to replace professional medical advice by the oncologist or other competent professionals in oncological diseases. The online pharmacy warns that the patient should beware of misinterpreting this material about Femara.
Femara Side Effects
Femara is used to treat breast cancer and normally is well tolerated by patients. The undesirable effects, resulting from the treatment with this antitumour drug, are mild to moderate in nature. Some women, taking aromatase inhibitor for 5 years, often complained at: dyslipidemia, hyperhidrosis, hot flushes, joint pain, and fatigue (incl. asthenia and malaise).
Treatment with Femara for longer than 8 years may cause such undesirable effects, as: stable angina, fractures, heart attack, endometrial polyp, abnormal vaginal bleeding, and cataract. It should be noted that such serious undesirable effects are extremely rare.